Actinium Pharmaceuticals (ATNM) Return on Sales [ROS] (2018 - 2026)
Actinium Pharmaceuticals' Return on Sales [ROS] was 78.76% in Q2 2026.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) Return on Sales [ROS] (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Actinium Pharmaceuticals' Return on Sales [ROS] was 26.53% through Jun 30, 2026; for FY2025, it was -40274.44%.
- Return on Sales [ROS] shows a five-year change of -27694.11 percentage points (FY2020 to FY2025).
- In earlier years, Return on Sales [ROS] was -64098.77% in FY2023 (-60787.70 pp), -3311.07% in FY2022 (-1128.90 pp) and -2182.17% in FY2021 (+10398.17 pp).
- The Q2 2026 figure marks the highest quarterly Return on Sales [ROS] in data going back to Q1 2018.
- The best year-over-year quarter for Return on Sales [ROS] over five years was Q4 2022 (a gain of 31680.24 percentage points); the worst was Q4 2021 (a drop of 23291.30 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Actinium Pharmaceuticals | 49.05 Mn | -130.95 Mn | - | 78.76% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78.76% |
| Mar 31, 2026 | -1,549.34% |
| Dec 31, 2025 | -2,561.63% |
| Sep 30, 2025 | -6,324.44% |
| Jun 30, 2025 | -1,200.48% |
| Mar 31, 2025 | -2,376.86% |
| Sep 30, 2024 | -1,219.85% |
| Jun 30, 2024 | -1,166.01% |
| Mar 31, 2024 | -1,035.28% |
| Dec 31, 2023 | -1,015.01% |
| Sep 30, 2023 | -1,334.98% |
| Jun 30, 2023 | -3,393.06% |
| Mar 31, 2023 | -2,117.73% |
| Dec 31, 2022 | -3,311.07% |
| Sep 30, 2022 | -21,775.56% |
| Jun 30, 2022 | -17,444.44% |
| Mar 31, 2022 | -549.36% |
| Dec 31, 2021 | -34,991.30% |
| Sep 30, 2021 | -2,776.39% |
| Jun 30, 2021 | -1,907.89% |
API Access
Actinium Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();